Mackay Shields LLC has filed its 13F form on July 24, 2025 for Q2 2025 where it was disclosed a total value porftolio of $482 Million distributed in 364 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Nuveen Amt Free Quality Municipal Income Fund with a value of $43.7M, Nuveen Municipal Credit Income Fund with a value of $35.4M, Ishares Gold Trust with a value of $34.6M, Black Rock Municipal 2030 Target Term Trust with a value of $34.2M, and Nuveen Amt Free Municipal Credit Income Fund with a value of $28.8M.
Examining the 13F form we can see an decrease of $31.5M in the current position value, from $514M to 482M .
Below you can find more details about Mackay Shields LLC portfolio as well as his latest detailed transactions.
Portfolio value
$482 Million
Financial Services: $390 Million
Energy: $45.5 Million
ETFs: $39.3 Million
Communication Services: $6.3 Million
Consumer Defensive: $515,000
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.59%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 18.11%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.54%
American Airlines Group Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 68.35%
Amphastar Pharmaceuticals In
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 13.31%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.52%
Ares Management Corporation
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.42%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 39.43%
-
$0
0.0% of portfolio
-
Q4 2024
Added 1.14%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 99.28%
Biomarin Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 19.36%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.5%
-
$0
0.0% of portfolio
-
Q2 2025
Added 35.95%
Envista Holdings Corporation
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.62%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.31%
-
$0
0.0% of portfolio
-
Q2 2025
Added 65.39%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.34%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.59%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.08%
Live Nation Entertainment In
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 3.75%
-
$0
0.0% of portfolio
-
Q1 2025
Added 1.48%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 3.8%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 23.16%
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 3.39%
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 9.74%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 3.85%
-
$0
0.0% of portfolio
-
Q4 2024
Added 5.95%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 35.58%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.23%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 19.1%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.51%
Hewlett Packard Enterprise C
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.57%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.35%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 4.26%
Microchip Technology Inc.
-
$0
0.0% of portfolio
-
Q2 2025
Added 20.44%